120 related articles for article (PubMed ID: 214985)
1. Hepatoma development during long term follow-up period of liver cirrhosis.
Kobayashi K; Kumagai M; Kameda S; Sugimoto T; Suzuki K; Nishimura K; Kato Y; Sugioka G; Hattori N
Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):344-9. PubMed ID: 214985
[TBL] [Abstract][Full Text] [Related]
2. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
[TBL] [Abstract][Full Text] [Related]
3. A comparison between hepatocellular carcinoma-developing and non-carcinoma-developing patients with cirrhosis over a long follow-up period.
Kobayashi K; Unoura M; Tanaka N; Hattori N
Hepatogastroenterology; 1990 Oct; 37(5):445-8. PubMed ID: 2174821
[TBL] [Abstract][Full Text] [Related]
4. Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases.
Sakurai M; Miyaji T
Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):334-9. PubMed ID: 73335
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hepatitis B antigen in cirrhosis and hepatoma in Thailand. An etiological significance.
Chanuvati T; Viranuvatti V; Pongpipat D
Gastroenterology; 1975 May; 68(5 Pt 1):1261-4. PubMed ID: 47828
[TBL] [Abstract][Full Text] [Related]
6. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study.
Sundaram C; Reddy CR; Ramana GV; Benerjea S; Venkataratnam G; Kumari GS; Reddy BS; Bhaskaran CS
Indian J Pathol Microbiol; 1990 Oct; 33(4):334-8. PubMed ID: 1966741
[TBL] [Abstract][Full Text] [Related]
8. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
Espinoza CG; Pillarisetti SG; Azar HA
Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
Volc-Platzer B; Hanak H; Weiss W; Denk H
Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
Swenson PD; Escobar MR; Silverman JF
Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
13. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
17. [Increased incidence of hepatocellular carcinoma in abstinent patients with alcoholic cirrhosis].
Nishiuchi M; Shinji Y
Gan To Kagaku Ryoho; 1990 Jan; 17(1):1-6. PubMed ID: 2153367
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
19. [HBS Ag-positive hepatocellular cancer (pathomorphologic study)].
Bardadin K; Kobushevska-Farina M
Arkh Patol; 1979; 41(8):45-9. PubMed ID: 226040
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]